AirSculpt Technologies, Inc. (AIRS)

NASDAQ: AIRS · Real-Time Price · USD
2.480
+0.030 (1.22%)
Apr 28, 2026, 2:34 PM EDT - Market open
1.22%
Market Cap 174.95M
Revenue (ttm) 151.82M
Net Income (ttm) -11.67M
Shares Out 70.55M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 410,788
Open 2.420
Previous Close 2.450
Day's Range 2.345 - 2.480
52-Week Range 1.510 - 12.000
Beta 2.27
Analysts n/a
Price Target n/a
Earnings Date May 12, 2026

About AIRS

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an adv... [Read more]

Sector Healthcare
IPO Date Oct 29, 2021
Employees 363
Stock Exchange NASDAQ
Ticker Symbol AIRS
Full Company Profile

Financial Performance

In 2025, AirSculpt Technologies's revenue was $151.82 million, a decrease of -15.82% compared to the previous year's $180.35 million. Losses were -$11.67 million, 45.5% more than in 2024.

Financial Statements

News

CORRECTION -- AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results

MIAMI BEACH, Fla., April 06, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 2nd, 2026, by AirSculpt Technologies, Inc. (NASDAQ:AIRS), please note that the Company determ...

22 days ago - GlobeNewsWire

AirSculpt Technologies Earnings Call Transcript: Q4 2025

Sequential improvement in same-store sales and adjusted EBITDA marked Q4 2025, with new services and enhanced marketing driving stabilization. 2026 guidance anticipates modest revenue growth, continued deleveraging, and no new center openings as focus remains on existing operations.

26 days ago - Transcripts

AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results

MIAMI BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announc...

26 days ago - GlobeNewsWire

AirSculpt Technologies Announces Fourth Quarter and Fiscal Year 2025 Earnings Release Date and Conference Call

MIAMI BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced i...

27 days ago - GlobeNewsWire

AirSculpt Technologies Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, March 18, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of AirSculpt Technologies, Inc. (NASDAQ: AIRS). The investigation focuses on...

5 weeks ago - GlobeNewsWire

AirSculpt Technologies Announces Its Intent to Delay the Filing of its Annual Report and Provides Business Update

Preliminary Fiscal Year 2025 Revenue of $151.8 Million Refreshed Marketing Strategy Delivers Positive Same-Store Sales in February 2026 Strong Balance Sheet and Enhanced Liquidity MIAMI BEACH, Fla., M...

6 weeks ago - GlobeNewsWire

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: NOTVSTIM
5 months ago - Benzinga

AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board

MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announce...

5 months ago - GlobeNewsWire

AirSculpt Technologies Earnings Call Transcript: Q3 2025

Q3 revenue declined 17.8% year-over-year amid a challenging consumer environment, but cost controls and new GLP-1-related services are positioning the business for future growth. 2025 revenue guidance was lowered, while EBITDA is expected at the low end of prior guidance.

6 months ago - Transcripts

AirSculpt Technologies Reports Third Quarter Fiscal 2025 Results

MIAMI BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announce...

6 months ago - GlobeNewsWire

AirSculpt Technologies Announces Third Quarter Fiscal 2025 Earnings Release Date and Conference Call

MIAMI BEACH, Fla., Oct. 31, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it...

6 months ago - GlobeNewsWire

AirSculpt Technologies Transcript: Sidoti Micro Cap Virtual Conference

The business operates 32 high-end body contouring centers, generating $180 million in 2024 revenue and $21 million adjusted EBITDA. Strategic focus is on same-store growth, marketing efficiency, and new service pilots, with strong cash flow supporting debt reduction and future expansion opportunities.

8 months ago - Transcripts

AirSculpt Technologies Announces Participation in Sidoti Micro Cap Conference

MIAMI BEACH, Fla., Aug. 13, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ: AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announ...

9 months ago - GlobeNewsWire

AirSculpt Technologies Earnings Call Transcript: Q2 2025

Q2 2025 saw revenue decline 13.7% year-over-year to $44M, with Adjusted EBITDA at $5.8M and improved cost management. Guidance for 2025 is reiterated, with no new centers planned and a focus on same-store sales amid a challenging consumer environment.

9 months ago - Transcripts

AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results

MIAMI BEACH, Fla., Aug. 01, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announce...

9 months ago - GlobeNewsWire

AirSculpt Technologies Announces Second Quarter Fiscal 2025 Earnings Release Date and Conference Call

MIAMI BEACH, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced i...

9 months ago - GlobeNewsWire

AirSculpt Strengthens Balance Sheet with $10.0 Million Debt Paydown

MIAMI BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS), a national provider of premium body contouring procedures, today announced the voluntary...

11 months ago - GlobeNewsWire

AirSculpt Announces Closing of Offering of Common Stock and Underwriters' Full Exercise of Option to Purchase Additional Shares

MIAMI BEACH, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announce...

11 months ago - GlobeNewsWire

AirSculpt Announces Pricing of Offering of Common Stock

MIAMI BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announce...

11 months ago - GlobeNewsWire

AirSculpt Announces Public Offering of Common Stock

MIAMI BEACH, Fla., June 09, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announc...

11 months ago - GlobeNewsWire

AirSculpt Technologies Earnings Call Transcript: Q1 2025

Q1 2025 saw a 17.3% revenue decline and lower case volumes, but improved marketing efficiency and cost discipline led to sequential EBITDA gains. Guidance for 2025 anticipates $160–$170 million in revenue and a return to same-store sales growth by year-end.

1 year ago - Transcripts

AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance

MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced...

1 year ago - GlobeNewsWire

AirSculpt Technologies Earnings Call Transcript: Q4 2024

Q4 2024 revenue fell 17.7% year-over-year, with same-store sales down 22.6% and adjusted EBITDA margin dropping to 4.7%. Strategic priorities include pausing new openings, focusing on same-center growth, and piloting new services, while cost savings and increased marketing aim to drive recovery.

1 year ago - Transcripts

AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results

MIAMI BEACH, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announc...

1 year ago - GlobeNewsWire

AirSculpt Technologies Announces Fourth Quarter Fiscal 2024 Earnings Release Date and Conference Call

MIAMI BEACH, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced i...

1 year ago - GlobeNewsWire